Japan's Mitsubishi Tanabe Pharma to buy Israel's Neuroderm for $1.1 bln
TOKYO, July 24 (Reuters) - Japan's Mitsubishi Tanabe Pharma Corp said on Monday it will acquire Israeli drug maker Neuroderm for $1.1 billion in an all-cash deal to expand its overseas business.
(Reporting by Sam Nussey; Editing by Muralikumar Anantharaman)
Terms and Privacy Policy